Ralph, Anna PYeo, Tsin W.Salome, CherylWaramori, GPontororing, Gysje JKenangalem, EnnySandjaja, .Tjitra, EmilianaLumb, RichardMaguire, Graeme P.Price, Ric NChatfield, Mark DKelly, PaulAnstey, Nicholas2015-12-131201-9712http://hdl.handle.net/1885/74015Background. Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FENO) andKeywords: arginine; nitric oxide; vitamin D; adolescent; adult; aged; article; bacterial clearance; controlled study; disease association; disease severity; female; follow up; forced vital capacity; human; lung tuberculosis; major clinical study; male; Papua New Gu Biomarker; Exhaled nitric oxide; L-arginine; M2 macrophages; TuberculosisImpaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: Association with disease severity and delayed mycobacterial clearance with treatment201310.1093/infdis/jit2482016-02-24